CID 16227481

(1z)-2-(1h-benzimidazol-2-yl)-1-thien-2-ylethanone oxime

Structural Information

Molecular Formula
C13H11N3OS
SMILES
C1=CC=C2C(=C1)NC(=N2)C/C(=N/O)/C3=CC=CS3
InChI
InChI=1S/C13H11N3OS/c17-16-11(12-6-3-7-18-12)8-13-14-9-4-1-2-5-10(9)15-13/h1-7,17H,8H2,(H,14,15)/b16-11-
InChIKey
RNXDQPRNNRNWSG-WJDWOHSUSA-N
Compound name
(NZ)-N-[2-(1H-benzimidazol-2-yl)-1-thiophen-2-ylethylidene]hydroxylamine
Related CIDs

2D Structure

compound 2d structure
1
Annotation Hits

0
References

0
Patents

257.0623 Da
Monoisotopic Mass

3.1
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 258.06958 154.8
[M+Na]+ 280.05152 166.7
[M+NH4]+ 275.09612 163.2
[M+K]+ 296.02546 161.7
[M-H]- 256.05502 157.9
[M+Na-2H]- 278.03697 161.8
[M]+ 257.06175 157.7
[M]- 257.06285 157.7
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

No literature data available for this compound.

Patent stripe

No patent data available for this compound.